(Post-pandemic Era) - Global Gastrointestinal Drugs Market Assessment, With Major Companies Analysis, Regional Analysis, Breakdown Data by Application/Type 2021

(Post-pandemic Era) - Global Gastrointestinal Drugs Market Assessment, With Major Companies Analysis, Regional Analysis, Breakdown Data by Application/Type 2021

Table of Contents

Global Gastrointestinal Drugs Market Analysis 2021, With Top Companies, Production, Revenue, Consumption, Price and Growth Rate
1 Market Scope
1.1 Product Details and Introduction
1.1.1 Acid Neutralizers -Product Introduction and Major Manufacturers
1.1.2 Antidiarrheal and Laxatives -Product Introduction and Major Manufacturers
1.1.3 Antiemetic and Antinauseants -Product Introduction and Major Manufacturers
1.1.4 Anti-inflammatory Drugs -Product Introduction and Major Manufacturers
1.1.5 Biologics -Product Introduction and Major Manufacturers
1.1.6 Others -Product Introduction and Major Manufacturers
1.2 Market Snapshot
1.2.1 Major Companies Overview
1.2.2 Market Concentration
1.2.3 Six-Year Compound Annual Growth Rate (CAGR)
2 Regional Market
2.1 Regional Market Share in Terms of Production (2020-2027)
2.2 Regional Market Share in Terms of Revenue (2020-2027)
2.3 Regional Market Share in Terms of Consumption (2020-2027)
3 Global Gastrointestinal Drugs Market Assessment by Type
3.1 Global Gastrointestinal Drugs Production by Type (2016-2027)
3.2 Global Gastrointestinal Drugs Revenue by Type (2016-2027)
3.3 North America Gastrointestinal Drugs Production and Revenue by Type (2016-2027)
3.4 Asia Gastrointestinal Drugs Production and Revenue by Type (2016-2027)
3.5 Europe Gastrointestinal Drugs Production and Revenue by Type (2016-2027)
3.6 Middle East & Africa Gastrointestinal Drugs Production and Revenue by Type (2016-2027)
3.7 South America Gastrointestinal Drugs Production and Revenue by Type (2016-2027)
4 Global Gastrointestinal Drugs Market Assessment by Application
4.1 Historical & Forecast Global Gastrointestinal Drugs Consumption, Different Application Field (2016-2027)
4.2 Historical & Forecast North America Gastrointestinal Drugs Consumption, Different Application Field (2016-2027)
4.3 Historical & Forecast Asia Gastrointestinal Drugs Consumption, Different Application Field (2016-2027)
4.4 Historical & Forecast Europe Gastrointestinal Drugs Consumption, Different Application Field (2016-2027)
4.5 Historical & Forecast Middle East & Africa Gastrointestinal Drugs Consumption, Different Application Field (2016-2027)
4.6 Historical & Forecast South America Gastrointestinal Drugs Consumption, Different Application Field (2016-2027)
5 North America
5.1 US Gastrointestinal Drugs Capacity, Production, Consumption and Proportion of Products Sold (2016-2027)
5.2 Canada Gastrointestinal Drugs Capacity, Production, Consumption and Proportion of Products Sold (2016-2027)
5.3 Mexico Gastrointestinal Drugs Capacity, Production, Consumption and Proportion of Products Sold (2016-2027)
6 Asia
6.1 China Gastrointestinal Drugs Capacity, Production, Consumption and Proportion of Products Sold (2016-2027)
6.2 Japan Gastrointestinal Drugs Capacity, Production, Consumption and Proportion of Products Sold (2016-2027)
6.3 India Gastrointestinal Drugs Capacity, Production, Consumption and Proportion of Products Sold (2016-2027)
6.4 Korea Gastrointestinal Drugs Capacity, Production, Consumption and Proportion of Products Sold (2016-2027)
6.5 Southeat Asia Gastrointestinal Drugs Capacity, Production, Consumption and Proportion of Products Sold (2016-2027)
7 Europe
7.1 Germany Gastrointestinal Drugs Capacity, Production, Consumption and Proportion of Products Sold (2016-2027)
7.2 UK Gastrointestinal Drugs Capacity, Production, Consumption and Proportion of Products Sold (2016-2027)
7.3 France Gastrointestinal Drugs Capacity, Production, Consumption and Proportion of Products Sold (2016-2027)
7.4 Russia Gastrointestinal Drugs Capacity, Production, Consumption and Proportion of Products Sold (2016-2027)
7.5 Italy Gastrointestinal Drugs Capacity, Production, Consumption and Proportion of Products Sold (2016-2027)
8 Middle East and Africa
8.1 Saudi Gastrointestinal Drugs Capacity, Production, Consumption and Proportion of Products Sold (2016-2027)
8.2 UAE Gastrointestinal Drugs Capacity, Production, Consumption and Proportion of Products Sold (2016-2027)
8.3 Egypt Gastrointestinal Drugs Capacity, Production, Consumption and Proportion of Products Sold (2016-2027)
8.4 Nigeria Gastrointestinal Drugs Capacity, Production, Consumption and Proportion of Products Sold (2016-2027)
8.5 South Africa Gastrointestinal Drugs Capacity, Production, Consumption and Proportion of Products Sold (2016-2027)
9 South America
9.1 Brazil Gastrointestinal Drugs Capacity, Production, Consumption and Proportion of Products Sold (2016-2027)
9.2 Argentina Gastrointestinal Drugs Capacity, Production, Consumption and Proportion of Products Sold (2016-2027)
9.3 Colombia Gastrointestinal Drugs Capacity, Production, Consumption and Proportion of Products Sold (2016-2027)
10 Global Gastrointestinal Drugs Average Price Trend
10.1 Market Price for Each Type of Gastrointestinal Drugs in North America (2016-2027)
10.2 Market Price for Each Type of Gastrointestinal Drugs in Asia (2016-2027)
10.3 Market Price for Each Type of Gastrointestinal Drugs in Europe (2016-2027)
10.4 Market Price for Each Type of Gastrointestinal Drugs in Middle East & Africa (2016-2027)
10.5 Market Price for Each Type of Gastrointestinal Drugs in South America (2016-2027)
11 Value Chain (Impact of COVID-19)
11.1 Gastrointestinal Drugs Value Chain Analysis
11.1.1 Upstream
11.1.2 Downstream
11.2 COVID-19 Impact on Gastrointestinal Drugs Industry
11.2.1 Industrial Policy Issued Under the Epidemic Situation
11.3 Cost-Under the Epidemic Situation
11.3.1 Cost of Raw Material
11.4 Channel Analysis
11.4.1 Distribution Channel-Under the Epidemic Situation
11.4.2 Distributors
12 Gastrointestinal Drugs Competitive Analysis
12.1 Abbott Laboratories
12.1.1 Abbott Laboratories Company Profiles
12.1.2 Abbott Laboratories Product Introduction
12.1.3 Abbott Laboratories Gastrointestinal Drugs Production, Revenue (2015-2020)
12.1.4 SWOT Analysis
12.2 Allergan
12.2.1 Allergan Company Profiles
12.2.2 Allergan Product Introduction
12.2.3 Allergan Gastrointestinal Drugs Production, Revenue (2015-2020)
12.2.4 SWOT Analysis
12.3 AstraZeneca
12.3.1 AstraZeneca Company Profiles
12.3.2 AstraZeneca Product Introduction
12.3.3 AstraZeneca Gastrointestinal Drugs Production, Revenue (2015-2020)
12.3.4 SWOT Analysis
12.4 Bayer
12.4.1 Bayer Company Profiles
12.4.2 Bayer Product Introduction
12.4.3 Bayer Gastrointestinal Drugs Production, Revenue (2015-2020)
12.4.4 SWOT Analysis
12.5 Takeda Pharmaceutical
12.5.1 Boehringer Ingelheim Company Profiles
12.5.2 Boehringer Ingelheim Product Introduction
12.5.3 Boehringer Ingelheim Gastrointestinal Drugs Production, Revenue (2015-2020)
12.5.4 SWOT Analysis
12.6 GlaxoSmithKline
12.6.1 GlaxoSmithKline Company Profiles
12.6.2 GlaxoSmithKline Product Introduction
12.6.3 GlaxoSmithKline Gastrointestinal Drugs Production, Revenue (2015-2020)
12.6.4 SWOT Analysis
12.7 Janssen Biotech
12.7.1 Janssen Biotech Company Profiles
12.7.2 Janssen Biotech Product Introduction
12.7.3 Janssen Biotech Gastrointestinal Drugs Production, Revenue (2015-2020)
12.7.4 SWOT Analysis
12.8 Sanofi
12.8.1 Sanofi Company Profiles
12.8.2 Sanofi Product Introduction
12.8.3 Sanofi Gastrointestinal Drugs Production, Revenue (2015-2020)
12.8.4 SWOT Analysis
12.9 Takeda Pharmaceutical
12.9.1 Takeda Pharmaceutical Company Profiles
12.9.2 Takeda Pharmaceutical Product Introduction
12.9.3 Takeda Pharmaceutical Gastrointestinal Drugs Production, Revenue (2015-2020)
12.9.4 SWOT Analysis
12.10 Valeant Pharmaceuticals
12.10.1 Valeant Pharmaceuticals Company Profiles
12.10.2 Valeant Pharmaceuticals Product Introduction
12.10.3 Valeant Pharmaceuticals Gastrointestinal Drugs Production, Revenue (2015-2020)
12.10.4 SWOT Analysis
13 Conclusion

List of Tables and Figures

Figure Product Introduction
Table Production (K Units) and Revenue (Million USD) of Major Players (2016-2020)
Figure Global Gastrointestinal Drugs Production Market Share of Top 5 Players
Table CAGR of Major Market (2021-2026)
Table CAGR in Terms of Production of Each Type (2016-2027)
Table Regional Market Share in Terms of Production (2020-2027)
Figure Regional Market Share in Terms of Production (2019 - 2020)
Table Regional Market Share in Terms of Revenue (2020-2027)
Figure Regional Market Share in Terms of Revenue (2019 - 2020)
Figure Regional Market Share in Terms of Consumption (2019 - 2020)
Figure Regional Market Share in Terms of Consumption (2019 - 2020)
Table Global Gastrointestinal Drugs Production (K Unit) by Type (2016-2027)
Figure Global Gastrointestinal Drugs Production (K Unit) and Growth Rate (2016-2027)
Figure Global Gastrointestinal Drugs Production Market Share (%) by Type (2019 -2020)
Table Global Gastrointestinal Drugs Revenue (Million USD) by Type (2016-2027)
Figure Global Gastrointestinal Drugs Revenue (Million USD) and Growth Rate (2016-2027)
Figure Global Gastrointestinal Drugs Revenue Market Share (%) by Type (2019-2020)
Figure North America Gastrointestinal Drugs Production (K Unit) by Type (2016-2027)
Figure North America Gastrointestinal Drugs Production (K Unit) and Growth Rate (2016-2027)
Figure North America Gastrointestinal Drugs Revenue (Million USD) by Type (2016-2027)
Figure North America Gastrointestinal Drugs Revenue (Million USD) and Growth Rate (2016-2027)
Figure Asia Gastrointestinal Drugs Production (K Unit) by Type (2016-2027)
Figure Asia Gastrointestinal Drugs Production (K Unit) and Growth Rate (2016-2027)
Figure Asia Gastrointestinal Drugs Revenue (Million USD) by Type (2016-2027)
Figure Asia Gastrointestinal Drugs Revenue (Million USD) and Growth Rate (2016-2027)
Figure Europe Gastrointestinal Drugs Production (K Unit) by Type (2016-2027)
Figure Europe Gastrointestinal Drugs Production (K Unit) and Growth Rate (2016-2027)
Figure Europe Gastrointestinal Drugs Revenue (Million USD) by Type (2016-2027)
Figure Europe Gastrointestinal Drugs Revenue (Million USD) and Growth Rate (2016-2027)
Figure Middle East & Africa Gastrointestinal Drugs Production (K Unit) by Type (2016-2027)
Figure Middle East & Africa Gastrointestinal Drugs Production (K Unit) and Growth Rate (2016-2027)
Figure Middle East & Africa Gastrointestinal Drugs Revenue (Million USD) by Type (2016-2027)
Figure Middle East & Africa Gastrointestinal Drugs Revenue (Million USD) and Growth Rate (2016-2027)
Figure South America Gastrointestinal Drugs Production (K Unit) by Type (2016-2027)
Figure South America Gastrointestinal Drugs Production (K Unit) and Growth Rate (2016-2027)
Figure South America Gastrointestinal Drugs Revenue (Million USD) by Type (2016-2027)
Figure South America Gastrointestinal Drugs Revenue (Million USD) and Growth Rate (2016-2027)
Table Historical & Forecast Gastrointestinal Drugs Different Application Field Consumption (K Unit)
Figure Consumption (K Unit) and Growth Rate (2016-2027)
Figure Different Application Field Consumption Market Share (%) (2019-2020)
Table Historical & Forecast Gastrointestinal Drugs Different Application Field Consumption (K Unit)
Figure North America Gastrointestinal Drugs Consumption (K Unit) and Growth Rate (2016-2027)
Figure North America Gastrointestinal Drugs Consumption Market Share (%) by Application (2016-2027)
Table Historical & Forecast Gastrointestinal Drugs Different Application Field Consumption (K Unit)
Figure Asia Gastrointestinal Drugs Consumption (K Unit) and Growth Rate (2016-2027)
Figure Asia Gastrointestinal Drugs Consumption Market Share (%) by Application (2016-2027)
Table Historical & Forecast Gastrointestinal Drugs Different Application Field Consumption (K Unit)
Figure Europe Gastrointestinal Drugs Consumption (K Unit) and Growth Rate (2016-2027)
Figure Europe Gastrointestinal Drugs Consumption Market Share (%) by Application (2016-2027)
Table Historical & Forecast Gastrointestinal Drugs Different Application Field Consumption (K Unit)
Figure Middle East & Africa Gastrointestinal Drugs Consumption (K Unit) and Growth Rate (2016-2027)
Figure Middle East & Africa Gastrointestinal Drugs Consumption Market Share (%) by Application (2016-2027)
Table Historical & Forecast Gastrointestinal Drugs Different Application Field Consumption (K Unit)
Figure South America Gastrointestinal Drugs Consumption (K Unit) and Growth Rate (2016-2027)
Figure South America Gastrointestinal Drugs Consumption Market Share (%) by Application (2016-2027)
Table Historical & Forecast Gastrointestinal Drugs Different Application Field Consumption (K Unit)
Table US Gastrointestinal Drugs Capacity (K Units), Production (K Units) and Consumption (K Units) (2016-2027) and Proportion of Products Sold
Figure Proportion of Products Sold (%) (2015 -2026)
Table Canada Gastrointestinal Drugs Capacity (K Units), Production (K Units) and Consumption (K Units) (2016-2027) and Proportion of Products Sold
Figure Proportion of Products Sold (%) (2015 -2026)
Table Mexico Gastrointestinal Drugs Capacity (K Units), Production (K Units) and Consumption (K Units) (2016-2027) and Proportion of Products Sold
Figure Proportion of Products Sold (%) (2015 -2026)
Table China Gastrointestinal Drugs Capacity (K Units), Production (K Units) and Consumption (K Units) (2016-2027) and Proportion of Products Sold
Figure Proportion of Products Sold (%) (2015 -2026)
Table Japan Gastrointestinal Drugs Capacity (K Units), Production (K Units) and Consumption (K Units) (2016-2027) and Proportion of Products Sold
Figure Proportion of Products Sold (%) (2015 -2026)
Table India Gastrointestinal Drugs Capacity (K Units), Production (K Units) and Consumption (K Units) (2016-2027) and Proportion of Products Sold
Figure Proportion of Products Sold (%) (2015 -2026)
Table Korea Gastrointestinal Drugs Capacity (K Units), Production (K Units) and Consumption (K Units) (2016-2027) and Proportion of Products Sold
Figure Proportion of Products Sold (%) (2015 -2026)
Table Southeast Asia Gastrointestinal Drugs Capacity (K Units), Production (K Units) and Consumption (K Units) (2016-2027) and Proportion of Products Sold
Figure Proportion of Products Sold (%) (2015 -2026)
Table Germany Gastrointestinal Drugs Capacity (K Units), Production (K Units) and Consumption (K Units) (2016-2027) and Proportion of Products Sold
Figure Proportion of Products Sold (%) (2015 -2026)
Table UK Gastrointestinal Drugs Capacity (K Units), Production (K Units) and Consumption (K Units) (2016-2027) and Proportion of Products Sold
Figure Proportion of Products Sold (%) (2015 -2026)
Table France Gastrointestinal Drugs Capacity (K Units), Production (K Units) and Consumption (K Units) (2016-2027) and Proportion of Products Sold
Figure Proportion of Products Sold (%) (2015 -2026)
Table Russia Gastrointestinal Drugs Capacity (K Units), Production (K Units) and Consumption (K Units) (2016-2027) and Proportion of Products Sold
Figure Proportion of Products Sold (%) (2015 -2026)
Table Italy Gastrointestinal Drugs Capacity (K Units), Production (K Units) and Consumption (K Units) (2016-2027) and Proportion of Products Sold
Figure Proportion of Products Sold (%) (2015 -2026)
Table Saudi Gastrointestinal Drugs Capacity (K Units), Production (K Units) and Consumption (K Units) (2016-2027) and Proportion of Products Sold
Figure Proportion of Products Sold (%) (2015 -2026)
Table UAE Gastrointestinal Drugs Capacity (K Units), Production (K Units) and Consumption (K Units) (2016-2027) and Proportion of Products Sold
Figure Proportion of Products Sold (%) (2015 -2026)
Table Egypt Gastrointestinal Drugs Capacity (K Units), Production (K Units) and Consumption (K Units) (2016-2027) and Proportion of Products Sold
Figure Proportion of Products Sold (%) (2015 -2026)
Table Nigeria Gastrointestinal Drugs Capacity (K Units), Production (K Units) and Consumption (K Units) (2016-2027) and Proportion of Products Sold
Figure Proportion of Products Sold (%) (2015 -2026)
Table South Africa Gastrointestinal Drugs Capacity (K Units), Production (K Units) and Consumption (K Units) (2016-2027) and Proportion of Products Sold
Figure Proportion of Products Sold (%) (2015 -2026)
Table Brazil Gastrointestinal Drugs Capacity (K Units), Production (K Units) and Consumption (K Units) (2016-2027) and Proportion of Products Sold
Figure Proportion of Products Sold (%) (2015 -2026)
Table Argentina Gastrointestinal Drugs Capacity (K Units), Production (K Units) and Consumption (K Units) (2016-2027) and Proportion of Products Sold
Figure Proportion of Products Sold (%) (2015 -2026)
Table Colombia Gastrointestinal Drugs Capacity (K Units), Production (K Units) and Consumption (K Units) (2016-2027) and Proportion of Products Sold
Figure Proportion of Products Sold (%) (2015 -2026)
Table Market Price (USD/Unit) for Each Type of Gastrointestinal Drugs in China
Table Market Price (USD/Unit) for Each Type of Gastrointestinal Drugs in EU
Table Market Price (USD/Unit) for Each Type of Gastrointestinal Drugs in USA
Table Market Price (USD/Unit) for Each Type of Gastrointestinal Drugs in Japan
Table Market Price (USD/Unit) for Each Type of Gastrointestinal Drugs in India
Table Market Price (USD/Unit) for Each Type of Gastrointestinal Drugs in Southeast Asia
Table Market Price (USD/Unit) for Each Type of Gastrointestinal Drugs in South America
Figure Value Chain Structure of Gastrointestinal Drugs
Table Value Chain
Table Key Suppliers of Raw Material/Components
Table Key Downstream Customer in Each Application Field
Table Industry News List of Gastrointestinal Drugs
Figure Cost Structure of Gastrointestinal Drugs in 2020
Table Distributors/Traders List
Table Abbott Laboratories Profiles
Table Abbott Laboratories Gastrointestinal Drugs Product Introduction
Figure Abbott Laboratories Gastrointestinal Drugs Capacity (Unit), Production (Unit), Revenue (Million USD) (2015-2020)
Figure Abbott Laboratories SWOT Analysis
Table Allergan Profiles
Table Allergan Gastrointestinal Drugs Product Introduction
Figure Allergan Gastrointestinal Drugs Capacity (Unit), Production (Unit), Revenue (Million USD) (2015-2020)
Figure Allergan SWOT Analysis
Table AstraZeneca Profiles
Table AstraZeneca Gastrointestinal Drugs Product Introduction
Figure AstraZeneca Gastrointestinal Drugs Capacity (Unit), Production (Unit), Revenue (Million USD) (2015-2020)
Figure AstraZeneca SWOT Analysis
Table Bayer Profiles
Table Bayer Gastrointestinal Drugs Product Introduction
Figure Bayer Gastrointestinal Drugs Capacity (Unit), Production (Unit), Revenue (Million USD) (2015-2020)
Figure Bayer SWOT Analysis
Table Boehringer Ingelheim Profiles
Table Boehringer Ingelheim Gastrointestinal Drugs Product Introduction
Figure Boehringer Ingelheim Medical Devices & Consumables Capacity (Unit), Production (Unit), Revenue (Million USD) (2015-2020)
Figure Boehringer Ingelheim SWOT Analysis
Table GlaxoSmithKline Profiles
Table GlaxoSmithKline Gastrointestinal Drugs Product Introduction
Figure GlaxoSmithKline Gastrointestinal Drugs Capacity (Unit), Production (Unit), Revenue (Million USD) (2015-2020)
Figure GlaxoSmithKline SWOT Analysis
Table Janssen Biotech Profiles
Table Janssen Biotech Gastrointestinal Drugs Product Introduction
Figure Janssen Biotech Gastrointestinal Drugs Capacity (Unit), Production (Unit), Revenue (Million USD) (2015-2020)
Figure Janssen Biotech SWOT Analysis
Table Sanofi Profiles
Table Sanofi Gastrointestinal Drugs Product Introduction
Figure Sanofi Gastrointestinal Drugs Capacity (Unit), Production (Unit), Revenue (Million USD) (2015-2020)
Figure Sanofi SWOT Analysis
Table Takeda Pharmaceutical Profiles
Table Takeda Pharmaceutical Gastrointestinal Drugs Product Introduction
Figure Takeda Pharmaceutical Gastrointestinal Drugs Capacity (Unit), Production (Unit), Revenue (Million USD) (2015-2020)
Figure Takeda Pharmaceutical SWOT Analysis
Table Valeant Pharmaceuticals Profiles
Table Valeant Pharmaceuticals Gastrointestinal Drugs Product Introduction
Figure Valeant Pharmaceuticals Gastrointestinal Drugs Capacity (Unit), Production (Unit), Revenue (Million USD) (2015-2020)

• Clinical Results in Diabetics To Be Boosted By Smart Artificial Beta Cells

For a long time, the cure for diabetes type 1 and type 2 has relied on agonizing insulin shots for patients or insulin infusion via mechanical pumps. Regarding this, experts have been creating artificial pancreatic beta cells with the he…

• High-speed Data Transmission And High Volume Needs Propel Fiber Optic Connectors Market

Fiber optic connectors are a substantial fragment of the global telecommunication industry. Optical fibers are joined using fiber optic connectors, which allow the light conduction between two consecutive optical fibers. An additional im…

• Extensive Use of Digital Technologies for Diagnostic Applications To Boost Global Optical Imaging Market

The global optical imaging system market is predicted to reach US$ 3 billion by 2024. It is expected to grow at a stable rate and will post a CAGR of more than 8% in the coming years. The growing market infiltration of digital …

• Foremost Trends In Global Pet Care Market

The global pet care market is foretold to improve in the forthcoming years as matched to the preceding years and will showcase better sales in various market segments. It is estimated that the global pet care market will grow at a CAGR o…

• China To Review Its Food Security Laws

China has arisen as the globe’s firmest developing economy. In addition, China brags about the biggest population pool in the world. In recent times, the one child policy in the republic was terminated. This is anticipated to upsur…

Global Anti-Peptic Ulcer Drugs Market Growth (Status and Outlook) 2024-2030

Published: 04-Jan-2024        Price: US 3660 Onwards        Pages: 110

According to our LPI (LP Information) latest study, the global Anti-Peptic Ulcer Drugs market size was valued at US$ 8523.5 million in 2023. With growing demand in downstream market, the Anti-Peptic Ulcer Drugs is forecast to a readjusted size of US$ 21200 million by 2030 with a CAGR of 13.9% during review period. The research report highlights the growth potential of the global Anti-Peptic Ulcer Drugs market. Anti-Peptic Ulcer Drugs are expected to show stable growth in the future marke......

Global Lansoprazole Market Research Report 2024

Published: 04-Jan-2024        Price: US 2900 Onwards        Pages: 102

The Lansoprazole market size, estimations, and forecasts are provided in terms of sales volume (K Units) and revenue ($ millions), considering 2023 as the base year, with history and forecast data for the period from 2019 to 2030. This report segments the global Lansoprazole market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided. For a more in-depth understanding of the market, the report provides profiles of the comp......

Global Irritable Bowel Syndrome (IBS) Market Growth (Status and Outlook) 2024-2030

Published: 04-Jan-2024        Price: US 3660 Onwards        Pages: 88

According to our LPI (LP Information) latest study, the global Irritable Bowel Syndrome (IBS) market size was valued at US$ 4634.2 million in 2023. With growing demand in downstream market, the Irritable Bowel Syndrome (IBS) is forecast to a readjusted size of US$ 12750 million by 2030 with a CAGR of 15.6% during review period. The research report highlights the growth potential of the global Irritable Bowel Syndrome (IBS) market. Irritable Bowel Syndrome (IBS) are expected to show stabl......

Global Esomeprazole Market Research Report 2024

Published: 04-Jan-2024        Price: US 2900 Onwards        Pages: 89

The Esomeprazole market size, estimations, and forecasts are provided in terms of sales volume (K Units) and revenue ($ millions), considering 2023 as the base year, with history and forecast data for the period from 2019 to 2030. This report segments the global Esomeprazole market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided. For a more in-depth understanding of the market, the report provides profiles of the comp......

Global Irritable Bowel Syndrome (IBS) Industry Research Report, In-depth Analysis of Current Status and Outlook of Key Countries 2023-2028

Published: 02-Jan-2024        Price: US 3380 Onwards        Pages: 126

Market Overview of Global Irritable Bowel Syndrome (IBS) market: According to our latest research, the global Irritable Bowel Syndrome (IBS) market looks promising in the next 5 years. As of 2022, the global Irritable Bowel Syndrome (IBS) market was estimated at USD XX million, and it's anticipated to reach USD XX million in 2028, with a CAGR of XX% during the forecast years. This report covers a research time span from 2018 to 2028, and presents a deep and comprehensive anal......

Global Diarrhea Drug Industry Research Report, In-depth Analysis of Current Status and Outlook of Key Countries 2023-2028

Published: 28-Dec-2023        Price: US 3380 Onwards        Pages: 109

Market Overview of Global Diarrhea Drug market: According to our latest research, the global Diarrhea Drug market looks promising in the next 5 years. As of 2022, the global Diarrhea Drug market was estimated at USD XX million, and it's anticipated to reach USD XX million in 2028, with a CAGR of XX% during the forecast years. This report covers a research time span from 2018 to 2028, and presents a deep and comprehensive analysis of the global Diarrhea Drug market, with a sys......

Drugs for Traveler's Diarrhea - Global Market Insights and Sales Trends 2024

Published: 27-Dec-2023        Price: US 3350 Onwards        Pages: 96

This report provides market insight on the different segments, by manufacturers, by Type, by Application. Market size and forecast (2018-2029) has been provided in the report. The primary objectives of this report are to provide 1) global market size and forecasts, growth rates, market dynamics, industry structure and developments, market situation, trends; 2) global market share and ranking By Company; 3) comprehensive presentation of the global market for Drugs for Traveler's Diarrhea, with bo......

Global Lansoprazole Professional Survey Report 2023, Forecast to 2028

Published: 26-Dec-2023        Price: US 3280 Onwards        Pages: 136

Lansoprazole reduces the amount of acid your stomach makes. It's used for indigestion, heartburn and acid reflux and gastroesophageal-reflux-disease (GORD). Lansoprazole is also taken to prevent and treat stomach ulcers. Our market research experts provide qualitative and quantitative analysis of the market based on involving economic and non-economic factors in the same report with market value (million USD) data for each segment and sub-segment. This way, clients can achieve all their g......

Global Pentasa (Ulcerative Colitis) Industry Research Report, In-depth Analysis of Current Status and Outlook of Key Countries 2023-2028

Published: 26-Dec-2023        Price: US 3380 Onwards        Pages: 113

Market Overview of Global Pentasa (Ulcerative Colitis) market: According to our latest research, the global Pentasa (Ulcerative Colitis) market looks promising in the next 5 years. As of 2022, the global Pentasa (Ulcerative Colitis) market was estimated at USD XX million, and it's anticipated to reach USD XX million in 2028, with a CAGR of XX% during the forecast years. This report covers a research time span from 2018 to 2028, and presents a deep and comprehensive analysis o......

We believe in "optimum utilization of available budget and resources". While servicing our clients' (your) market research requirements, we keep the same approach in focus to help you get the best value for your $$s. Ranging from the smallest feasible / required data (datasheets, data facts, SWOT analysis, company profiles, etc) to full research reports that help you make decisions, our inventory is updated almost on a daily basis with the latest industry reports from domain experts that track more than 5000 niche sectors. Need a custom research report on medical devices market? Require all available business intelligence on 3D printing industry? Exploring F&B sector of a particular country/region? RnRMarketResearch.com is your one-stop-solution to all market intelligence needs. We not only offer custom research and consulting services, we also "bundle" reports to meet your needs and help you fetch the data analysis you require for your business. Not limited to only "finding" relevant reports for you, our client engagement team dedicates its efforts to understand your "business need" and accordingly maps available research data to help you move forward. Call "your" client engagement executive any time of your day and get your questions answered in order to make the correct business decision. Simply share your research requirement details with us and let us do all the hard work to find required intelligence for you. When you add up our "one stop solution" and "dedicated client engagement" services mentioned above, you obviously know the time and effort saving you do by working with us. Working with Fortune 500 organizations, we understand the importance of being flexible for payments. Share your payment terms with us and we will surely match up to them to ensure you get access to required business intelligence data without having to wait for the payment to be done. Have questions after reading a report / datasheet bought through us? Not sure about the methodology used for data available in the research? Talk to us / Share your questions with us and if required, we will connect you with the analyst(s)/author(s) of the report(s) and ensure you get satisfactory answers for the same. Need more data / analysis / report(s) on the topic of your research/project? The RnRMarketResearch.com team is here for you 24X7 to support you with your post-purchase requirements. Subscription Offers & Packages (Get in touch with us for more details - [email protected] / +1 888 391 5441 )

• Ad Hoc
• Pay - as - you - go / Bucket Subscriptions
• Fixed Cost for #of reports
• Customize / Personalize as per your needs